Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Coiled-coil domain containing 85B suppresses the β-catenin activity in a p53-dependent manner

Abstract

Aberrant accumulation of β-catenin is closely related to carcinogenesis. Mutations in the p53 gene are reported to induce the aberrant accumulation of β-catenin in the absence of dysfunction in the glycogen synthase kinase 3β (GSK3β)-mediated degradation pathway, but the mechanism remains incompletely understood. Here, we show that human coiled-coil domain containing 85B (CCDC85B) is induced by p53 and regulates β-catenin activity via interaction with the T-cell factor 4 in the nucleus. Moreover, CCDC85B enhances the degradation of β-catenin and suppresses tumor cell growth. In conclusion, we revealed that CCDC85B-induced degradation of β-catenin is independent of GSK3β and other p53-inducible products, Siah-1L, suggesting that CCDC85B constitutes the one of the frameworks of p53-induced multiple regulatory pathways for β-catenin activity.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

Abbreviations

CCDC85B:

coiled-coil domain containing 85B

DOX:

doxorubicin

GSK3β:

glycogen synthase kinase 3β

LEF:

lymphocyte enhancer binding factor

LiCl:

lithium chloride

siRNA:

short interfering RNA

TCF:

T-cell factor

References

  • Brazas R, Ganem D . (1996). A cellular homolog of hepatitis delta antigen: implications for viral replication and evolution. Science 274: 90–94.

    Article  CAS  Google Scholar 

  • Cagatay T, Ozturk M . (2002). P53 mutation as a source of aberrant beta-catenin accumulation in cancer cells. Oncogene 21: 7971–7980.

    Article  CAS  Google Scholar 

  • Chung DC . (2000). The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis. Gastroenterology 119: 854–865.

    Article  CAS  Google Scholar 

  • Harris SL, Levine AJ . (2005). The p53 pathway: positive and negative feedback loops. Oncogene 24: 2899–2908.

    Article  CAS  Google Scholar 

  • Hart MJ, de los Santos R, Albert IN, Rubinfeld B, Polakis P . (1998). Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta. Curr Biol 8: 573–581.

    Article  CAS  Google Scholar 

  • He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT et al. (1998). Identification of c-MYC as a target of the APC pathway. Science 281: 1509–1512.

    Article  CAS  Google Scholar 

  • Henderson BR . (2000). Nuclear-cytoplasmic shuttling of APC regulates beta-catenin subcellular localization and turnover. Nat Cell Biol 2: 653–660.

    Article  CAS  Google Scholar 

  • Hurlstone A, Clevers H . (2002). T-cell factors: turn-ons and turn-offs. EMBO J 21: 2303–2311.

    Article  CAS  Google Scholar 

  • Iwai A, Marusawa H, Matsuzawa S, Fukushima T, Hijikata M, Reed JC et al. (2004). Siah-1L, a novel transcript variant belonging to the human Siah family of proteins, regulates beta-catenin activity in a p53-dependent manner. Oncogene 23: 7593–7600.

    Article  CAS  Google Scholar 

  • Klein PS, Melton DA . (1996). A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 93: 8455–8459.

    Article  CAS  Google Scholar 

  • Lee TK, Lau TC, Ng IO . (2002). Doxorubicin-induced apoptosis and chemosensitivity in hepatoma cell lines. Cancer Chemother Pharmacol 49: 78–86.

    Article  CAS  Google Scholar 

  • Lee E, Salic A, Kirschner MW . (2001). Physiological regulation of [beta]-catenin stability by Tcf3 and CK1epsilon. J Cell Biol 154: 983–993.

    Article  CAS  Google Scholar 

  • Matsuzawa SI, Reed JC . (2001). Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses. Mol Cell 7: 915–926.

    Article  CAS  Google Scholar 

  • Park WS, Oh RR, Park JY, Kim PJ, Shin MS, Lee JH et al. (2001). Nuclear localization of beta-catenin is an important prognostic factor in hepatoblastoma. J Pathol 193: 483–490.

    Article  CAS  Google Scholar 

  • Prange W, Breuhahn K, Fischer F, Zilkens C, Pietsch T, Petmecky K et al. (2003). Beta-catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53, but not with expression of conventional WNT-1 target genes. J Pathol 201: 250–259.

    Article  CAS  Google Scholar 

  • Roose J, Clevers H . (1999). TCF transcription factors: molecular switches in carcinogenesis. Biochim Biophys Acta 1424: M23–37.

    CAS  PubMed  Google Scholar 

  • Sadot E, Geiger B, Oren M, Ben-Ze'ev A . (2001). Down-regulation of beta-catenin by activated p53. Mol Cell Biol 21: 6768–6781.

    Article  CAS  Google Scholar 

  • Stambolic V, MacPherson D, Sas D, Lin Y, Snow B, Jang Y et al. (2001). Regulation of PTEN transcription by p53. Mol Cell 8: 317–325.

    Article  CAS  Google Scholar 

  • Tetsu O, McCormick F . (1999). Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398: 422–426.

    Article  CAS  Google Scholar 

  • Tolwinski NS, Wieschaus E . (2001). Armadillo nuclear import is regulated by cytoplasmic anchor Axin and nuclear anchor dTCF/Pan. Development 128: 2107–2117.

    CAS  PubMed  Google Scholar 

  • Watashi K, Hijikata M, Tagawa A, Doi T, Marusawa H, Shimotohno K . (2003). Modulation of retinoid signaling by a cytoplasmic viral protein via sequestration of Sp110b, a potent transcriptional corepressor of retinoic acid receptor, from the nucleus. Mol Cell Biol 23: 7498–7509.

    Article  CAS  Google Scholar 

  • Willert K, Nusse R . (1998). Beta-catenin: a key mediator of Wnt signaling. Curr Opin Genet Dev 8: 95–102.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by grants-in-aid for cancer research and for the second-term comprehensive 10-year strategy for cancer control from the Ministry of Health, Labour and Welfare as well as by Grant-in-Aid for Scientific Research on Priority Areas ‘Integrative Research Toward the Conquest of Cancer’ from the Ministry of Education, Culture, Sports, Science and Technology of Japan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K Shimotohno.

Additional information

Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc).

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Iwai, A., Hijikata, M., Hishiki, T. et al. Coiled-coil domain containing 85B suppresses the β-catenin activity in a p53-dependent manner. Oncogene 27, 1520–1526 (2008). https://doi.org/10.1038/sj.onc.1210801

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1210801

Keywords

This article is cited by

Search

Quick links